Developer docs
API playgroundTry for free, no card

Search company profiles

Research to Practice

Full company profile

uuid000f6p8

Namestring
Research to Practice
Legal namestring
Research To Practice
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Research to Practice (RTP) is a private, accredited medical education company founded in 1985 by medical oncologist Neil Love, MD, and headquartered in Key Biscayne (Miami), Florida. The company produces oncology and hematology continuing education content — including CME for physicians and NCPD for nurses — distributed to U.S. cancer clinicians across medical oncology, hematology, surgical oncology, radiation oncology, and advanced practice nursing. RTP's content library spans 300+ hours of accredited programming across 225+ activities and 400+ programs covering breast, lung, gastrointestinal, genitourinary, gynecologic, hematologic, and dermatologic cancers, delivered via a digital platform (researchtopractice.com), native iOS/Android apps, nine podcast series, live webinars, microlearning modules, and an annual national summit.

The underlying technology is a content-centric digital education platform with single sign-on, robust search, and direct integration into CME/NCPD certification systems (ACCME, ANCC, ABIM MOC, ABS Continuous Certification); the platform was fully redesigned and relaunched in June 2026. RTP operates a multi-format content engine (faculty presentations, symposium proceedings, one-on-one investigator interviews, case-based discussions, nursing symposia, Patterns of Care studies) produced with 260+ faculty members and clinical investigators. Following its November 2025 acquisition by Stamford-based healthcare communications firm The Lockwood Group, RTP continues to operate as a subsidiary under Dr. Love's leadership.

RTP's revenue model is entirely grant-funded: educational grants from 60+ pharmaceutical and biotech commercial supporters (including Gilead Sciences, Genentech/Roche, Pfizer, Merck, and Bristol Myers Squibb) underwrite content production, allowing all CME/NCPD activities to be offered complimentary to end users. The company generates no direct revenue from clinicians and prices content at zero to physicians and nurses. Go-to-market is event-driven and digital-first, leveraging flagship live events (Annual National General Medical Oncology Summit), webinars, podcasts, and institutional partnerships (Florida Cancer Specialists & Research Institute, American Oncology Network) to drive clinician engagement and, by extension, sustained pharma grant funding.

Short descriptiontext

Research to Practice is a private, accredited medical education company founded in 1985 by Dr. Neil Love that produces CME and NCPD content for U.S. oncology and hematology clinicians. Funded entirely by pharmaceutical educational grants, it distributes 300+ hours of accredited programming via a digital platform, mobile apps, podcasts, and live events.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology medical education, continuing medical education, accredited CME programs, nursing continuing education, oncology clinical education
Industry3 codes
PRIMARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAAALAC
Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
NAICS code2 codes
  • Educational Services611
  • Educational Support Services61171
SIC code1 code
  • Services-Educational Services8200
Product category
Continuing Medical Education (Oncology)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Educational Grants from Pharmaceutical Companies
TypeSubscription Recurring
Description

RTP operates as a medical education company funded by educational grants from pharmaceutical and biotech companies. The company receives funds from commercial supporters including companies like Gilead Sciences Inc, Genentech/Roche, Pfizer Inc, Merck, Bristol Myers Squibb, and over 60 other companies to develop CME/NCPD activities. This is the primary revenue model enabling complimentary access to healthcare professionals.

prnewswire.com
2Complimentary CME/NCPD Activities
TypeFreemium
Description

RTP offers a variety of complimentary CME/NCPD activities and series for physicians, nurses, and other healthcare professionals in practice. All educational content is provided free to end users, funded entirely by pharmaceutical company educational grants.

researchtopractice.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Complimentary access to all CME/NCPD accredited activities
ModelFreemiumBilling cadenceAnnual
Notes

All programs, including webinars, video interviews, symposium proceedings, and nursing education, are provided at no cost to physicians, nurses, and other healthcare professionals. Free registration required to access full content and claim credits.

researchtopractice.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Research To Practice produces and distributes accredited continuing medical education (CME) and nursing continuing professional development (NCPD) content for oncology and hematology clinicians in the United States. Its core deliverable is a digital education platform offering more than 300 hours of accredited programming across 225+ activities featuring 260+ clinical investigators as faculty, delivered via website, mobile apps, podcasts, live webinars, and in-person summits. RTP is funded by educational grants from pharmaceutical and biotech companies, allowing all CME/NCPD activities to be offered free of charge to healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Programs used by the vast majority of cancer clinicians in the United States
+2 more records
Product overview1 text field

Research To Practice operates a unified digital education platform offering accredited CME and NCPD content for oncology professionals. The portfolio includes the core digital platform (researchtopractice.com) with mobile apps for iOS and Android, plus an extensive library of podcasts (Oncology Today with Dr Neil Love, Breast Cancer Update, Hematologic Oncology Update, Gastrointestinal Cancer Update, Lung Cancer Update, Prostate Cancer Update, Gynecologic Cancer Update, Dermatologic Oncology Update) and video content. Content is organized into structured collections including What Clinicians Want to Know, Year in Review, Microlearning Activity, Oncology Today with Dr Neil Love, Nursing Symposium, and Expert Second Opinion, spanning tumor types (breast, GI, GU, hematologic, lung, gynecologic, dermatologic, multitumor) and formats (faculty presentations, webinars, symposium proceedings, nursing programs, microlearning, interviews). The company was acquired by The Lockwood Group in November 2025.

Product and service2 records
1Research To Practice Digital Platform
CategoryContinuing medical education platform
Description

Primary digital education platform at researchtopractice.com delivering accredited CME and NCPD content to oncology clinicians, with over 300 hours of programming across 225+ activities spanning breast, lung, GI, GU, gynecologic, hematologic, dermatologic, and multitumor oncology; includes single sign-on, robust search, and direct integration with ABIM MOC, ABS MOC, ACCME, and ANCC certification systems for seamless credit claiming.

2RTP Mobile App (iOS and Android)
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

Florida Cancer Specialists & Research Institute partnered with Research to Practice for the Fifth Annual National General Medical Oncology Summit in Orlando, Florida. This exclusive event convenes leading oncology experts to share cutting-edge data and emerging treatment strategies for personalized cancer care in community settings. FCS President Dr. Lucio N. Gordan emphasized the program delivers actionable insights supporting clinical and operational decision-making for medical oncologists and frontline cancer care professionals.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-12
Description

The Lockwood Group, a healthcare PR firm based in Stamford, Connecticut, acquired Research To Practice in November 2025. The deal expands The Lockwood Group's global healthcare services capabilities and enhances evidence-based resources and support for oncology clinicians worldwide. RTP, founded by Dr. Neil Love in Miami, provides oncology-focused medical education content and formats. The acquisition represents RTP's continued investment in accessible oncology education across digital, live, and on-demand channels under the parent company's umbrella.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research to Practice partnered with the American Oncology Network for the AON 2025 event, delivering a multitumor symposium titled 'Integrating New Advances into the Care of Patients with Cancer' covering lung cancer, chronic lymphocytic leukemia, and other topics. This partnership brings RTP's educational content to AON's network of community oncology practices.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Operated by WebMD, Medscape Education is the largest free online CME/CE destination for clinicians globally. It overlaps directly with RTP in oncology CME offerings and competes for the same pharma educational grant dollars, though across many more therapeutic areas.

TypeDirect peer
Description

CCO is a privately-held medical education company offering accredited CME/CE across oncology, HIV, and other specialties. It competes with RTP directly for pharma educational grants in oncology and operates a similar digital, live-event, and expert-interview content model.

TypeOthers
Description

MedPage Today provides oncology news and accredited CME activities to practicing clinicians and competes with RTP for clinician attention and pharma-sponsored education budgets across overlapping specialist audiences.

TypeBroad incumbent
Description

Haymarket's medical education division delivers accredited CME/CE across multiple specialties including oncology through its mycme.com platform. It is comparable to RTP as a pharma-grant-funded CME publisher with multi-specialty reach.

TypeDirect peer
Description

MJH Life Sciences' OncLive platform provides oncology-focused news, interviews, and CME activities targeted at the same practicing oncologist audience as RTP. Both produce interview-driven, faculty-led content under pharma-supported models.

TypeDirect peer
Description

Vindico is an accredited provider of CME/CE content using a pharma-supported, expert-faculty model for specialist audiences including oncology. It directly competes with RTP for sponsor grants and clinician engagement in specialty CME.

TypeDirect peer
Description

PlatformQ Health produces digital CME/CE activities (webinars, online symposia, video interviews) for clinicians, including oncology content funded by pharma grants. It is directly comparable to RTP in digital-first CME delivery.

TypeOthers
Description

NCCN is a not-for-profit alliance of leading cancer centers producing clinical practice guidelines and accredited oncology education. While not for-profit and not grant-funded in the same way, it competes with RTP for clinician mindshare in oncology decision-making content.

TypeBroad incumbent
Description

Owned by MDEdge, Pri-Med is a large CME provider serving primary care and specialty clinicians through live conferences and online education. It overlaps with RTP at the broader CME/grant-funded intersection and competes for shared sponsor budgets.

TypeDirect peer
Description

PER designs oncology-specific CME-certified activities, including live meetings, symposia, and online programs funded by pharma grants. It overlaps with RTP in audience, funding model, and content format (live symposia + enduring CME).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Research to Practice

Continuing Medical Education (Oncology)researchtopractice.com

Research to Practice is a private, accredited medical education company founded in 1985 by Dr. Neil Love that produces CME and NCPD content for U.S. oncology and hematology clinicians. Funded entirely by pharmaceutical educational grants, it distributes 300+ hours of accredited programming via a digital platform, mobile apps, podcasts, and live events.

What Research to Practice does

Research to Practice (RTP) is a private, accredited medical education company founded in 1985 by medical oncologist Neil Love, MD, and headquartered in Key Biscayne (Miami), Florida. The company produces oncology and hematology continuing education content — including CME for physicians and NCPD for nurses — distributed to U.S. cancer clinicians across medical oncology, hematology, surgical oncology, radiation oncology, and advanced practice nursing. RTP's content library spans 300+ hours of accredited programming across 225+ activities and 400+ programs covering breast, lung, gastrointestinal, genitourinary, gynecologic, hematologic, and dermatologic cancers, delivered via a digital platform (researchtopractice.com), native iOS/Android apps, nine podcast series, live webinars, microlearning modules, and an annual national summit.

The underlying technology is a content-centric digital education platform with single sign-on, robust search, and direct integration into CME/NCPD certification systems (ACCME, ANCC, ABIM MOC, ABS Continuous Certification); the platform was fully redesigned and relaunched in June 2026. RTP operates a multi-format content engine (faculty presentations, symposium proceedings, one-on-one investigator interviews, case-based discussions, nursing symposia, Patterns of Care studies) produced with 260+ faculty members and clinical investigators. Following its November 2025 acquisition by Stamford-based healthcare communications firm The Lockwood Group, RTP continues to operate as a subsidiary under Dr. Love's leadership.

RTP's revenue model is entirely grant-funded: educational grants from 60+ pharmaceutical and biotech commercial supporters (including Gilead Sciences, Genentech/Roche, Pfizer, Merck, and Bristol Myers Squibb) underwrite content production, allowing all CME/NCPD activities to be offered complimentary to end users. The company generates no direct revenue from clinicians and prices content at zero to physicians and nurses. Go-to-market is event-driven and digital-first, leveraging flagship live events (Annual National General Medical Oncology Summit), webinars, podcasts, and institutional partnerships (Florida Cancer Specialists & Research Institute, American Oncology Network) to drive clinician engagement and, by extension, sustained pharma grant funding.

Research to Practice firmographics

Firmographics
Name
Research to Practice
Legal name
Research To Practice
Website
https://researchtopractice.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
51–100 employees
Short description
Research to Practice is a private, accredited medical education company founded in 1985 by Dr. Neil Love that produces CME and NCPD content for U.S. oncology and hematology clinicians. Funded entirely by pharmaceutical educational grants, it distributes 300+ hours of accredited programming via a digital platform, mobile apps, podcasts, and live events.
Ownership category
akta.pro rank

Research to Practice industry classification

Industry
Product category
Continuing Medical Education (Oncology)
NAICS
Educational Services (611), Educational Support Services (61171)
SIC
Services-Educational Services (8200)
akta.pro industry
PRIMARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
SECONDARYEDAAALAC
Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing

Keywords

  • Oncology medical education
  • Continuing medical education
  • Accredited CME programs
  • Nursing continuing education
  • Oncology clinical education

Where Research to Practice is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Research to Practice business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Educational Grants from Pharmaceutical Companies: RTP operates as a medical education company funded by educational grants from pharmaceutical and biotech companies. The company receives funds from commercial supporters including companies like Gilead Sciences Inc, Genentech/Roche, Pfizer Inc, Merck, Bristol Myers Squibb, and over 60 other companies to develop CME/NCPD activities. This is the primary revenue model enabling complimentary access to healthcare professionals.
  2. Complimentary CME/NCPD Activities: RTP offers a variety of complimentary CME/NCPD activities and series for physicians, nurses, and other healthcare professionals in practice. All educational content is provided free to end users, funded entirely by pharmaceutical company educational grants.

Pricing tiers

ModelBillingPrice
FreemiumAnnualComplimentary access to all CME/NCPD accredited activities

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Research to Practice product offering

Product offering

Core offering

Research To Practice produces and distributes accredited continuing medical education (CME) and nursing continuing professional development (NCPD) content for oncology and hematology clinicians in the United States. Its core deliverable is a digital education platform offering more than 300 hours of accredited programming across 225+ activities featuring 260+ clinical investigators as faculty, delivered via website, mobile apps, podcasts, live webinars, and in-person summits. RTP is funded by educational grants from pharmaceutical and biotech companies, allowing all CME/NCPD activities to be offered free of charge to healthcare professionals.

Product overview

Research To Practice operates a unified digital education platform offering accredited CME and NCPD content for oncology professionals. The portfolio includes the core digital platform (researchtopractice.com) with mobile apps for iOS and Android, plus an extensive library of podcasts (Oncology Today with Dr Neil Love, Breast Cancer Update, Hematologic Oncology Update, Gastrointestinal Cancer Update, Lung Cancer Update, Prostate Cancer Update, Gynecologic Cancer Update, Dermatologic Oncology Update) and video content. Content is organized into structured collections including What Clinicians Want to Know, Year in Review, Microlearning Activity, Oncology Today with Dr Neil Love, Nursing Symposium, and Expert Second Opinion, spanning tumor types (breast, GI, GU, hematologic, lung, gynecologic, dermatologic, multitumor) and formats (faculty presentations, webinars, symposium proceedings, nursing programs, microlearning, interviews). The company was acquired by The Lockwood Group in November 2025.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research To Practice Digital Platform Primary digital education platform at researchtopractice.com delivering accredited CME and NCPD content to oncology clinicians, with over 300 hours of programming across 225+ activities spanning breast, lung, GI, GU, gynecologic, hematologic, dermatologic, and multitumor oncology; includes single sign-on, robust search, and direct integration with ABIM MOC, ABS MOC, ACCME, and ANCC certification systems for seamless credit claiming.
  • RTP Mobile App (iOS and Android)

Quantifiable outcome

  • Programs used by the vast majority of cancer clinicians in the United States
  • +2 more outcomes

Companies that use Research to Practice

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Research to Practice technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Research to Practice partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • Florida Cancer Specialists & Research Institute (FCS)coreStrategic or Co-development Partner · 24 April 2026Florida Cancer Specialists & Research Institute partnered with Research to Practice for the Fifth Annual National General Medical Oncology Summit in Orlando, Florida. This exclusive event convenes leading oncology experts to share cutting-edge data and emerging treatment strategies for personalized cancer care in community settings. FCS President Dr. Lucio N. Gordan emphasized the program delivers actionable insights supporting clinical and operational decision-making for medical oncologists and frontline cancer care professionals.
  • The Lockwood GroupcoreStrategic or Co-development Partner · 12 November 2025The Lockwood Group, a healthcare PR firm based in Stamford, Connecticut, acquired Research To Practice in November 2025. The deal expands The Lockwood Group's global healthcare services capabilities and enhances evidence-based resources and support for oncology clinicians worldwide. RTP, founded by Dr. Neil Love in Miami, provides oncology-focused medical education content and formats. The acquisition represents RTP's continued investment in accessible oncology education across digital, live, and on-demand channels under the parent company's umbrella.
  • American Oncology Network (AON)majorStrategic or Co-development PartnerResearch to Practice partnered with the American Oncology Network for the AON 2025 event, delivering a multitumor symposium titled 'Integrating New Advances into the Care of Patients with Cancer' covering lung cancer, chronic lymphocytic leukemia, and other topics. This partnership brings RTP's educational content to AON's network of community oncology practices.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Research to Practice competitors and assessment

Company assessment

Broad incumbents

  • Medscape Education: Operated by WebMD, Medscape Education is the largest free online CME/CE destination for clinicians globally. It overlaps directly with RTP in oncology CME offerings and competes for the same pharma educational grant dollars, though across many more therapeutic areas.
  • Haymarket Medical Education: Haymarket's medical education division delivers accredited CME/CE across multiple specialties including oncology through its mycme.com platform. It is comparable to RTP as a pharma-grant-funded CME publisher with multi-specialty reach.
  • Pri-Med: Owned by MDEdge, Pri-Med is a large CME provider serving primary care and specialty clinicians through live conferences and online education. It overlaps with RTP at the broader CME/grant-funded intersection and competes for shared sponsor budgets.

Direct peers

  • Clinical Care Options (CCO): CCO is a privately-held medical education company offering accredited CME/CE across oncology, HIV, and other specialties. It competes with RTP directly for pharma educational grants in oncology and operates a similar digital, live-event, and expert-interview content model.
  • OncLive (MJH Life Sciences): MJH Life Sciences' OncLive platform provides oncology-focused news, interviews, and CME activities targeted at the same practicing oncologist audience as RTP. Both produce interview-driven, faculty-led content under pharma-supported models.
  • Vindico Medical Education: Vindico is an accredited provider of CME/CE content using a pharma-supported, expert-faculty model for specialist audiences including oncology. It directly competes with RTP for sponsor grants and clinician engagement in specialty CME.
  • PlatformQ Health: PlatformQ Health produces digital CME/CE activities (webinars, online symposia, video interviews) for clinicians, including oncology content funded by pharma grants. It is directly comparable to RTP in digital-first CME delivery.
  • Physicians' Education Resource (PER): PER designs oncology-specific CME-certified activities, including live meetings, symposia, and online programs funded by pharma grants. It overlaps with RTP in audience, funding model, and content format (live symposia + enduring CME).

Others

  • MedPage Today: MedPage Today provides oncology news and accredited CME activities to practicing clinicians and competes with RTP for clinician attention and pharma-sponsored education budgets across overlapping specialist audiences.
  • National Comprehensive Cancer Network (NCCN): NCCN is a not-for-profit alliance of leading cancer centers producing clinical practice guidelines and accredited oncology education. While not for-profit and not grant-funded in the same way, it competes with RTP for clinician mindshare in oncology decision-making content.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Research to Practice social profiles

Digital presence

Research to Practice compliance and trust

Trust signal

Compliance4 records

Research to Practice financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Research to Practice leadership team

Management profile

Number of profiles

Profiles2 records

Research to Practice funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Research to Practice M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research to Practice

What does Research to Practice do?

Research To Practice produces and distributes accredited continuing medical education (CME) and nursing continuing professional development (NCPD) content for oncology and hematology clinicians in the United States. Its core deliverable is a digital education platform offering more than 300 hours of accredited programming across 225+ activities featuring 260+ clinical investigators as faculty, delivered via website, mobile apps, podcasts, live webinars, and in-person summits. RTP is funded by educational grants from pharmaceutical and biotech companies, allowing all CME/NCPD activities to be offered free of charge to healthcare professionals.

Is Research to Practice a public or private company?

Research to Practice is a private company. It is classified as corporate owned and is currently operating.

When was Research to Practice founded?

Research to Practice was founded in 1988. It employs 51 to 100 people.

Where is Research to Practice based?

Research to Practice is headquartered in Miami, United States, in the North America region.

How does Research to Practice make money?

Two revenue lines are on record. Educational Grants from Pharmaceutical Companies are the primary driver. The others are complimentary CME/NCPD Activities.

Who are Research to Practice's main competitors?

Broad incumbents on record are Medscape Education, Haymarket Medical Education and Pri-Med. Direct peers are Clinical Care Options (CCO), OncLive (MJH Life Sciences), Vindico Medical Education, PlatformQ Health and Physicians' Education Resource (PER). Others are MedPage Today and National Comprehensive Cancer Network (NCCN).

Does Research to Practice have an API?

No public API is recorded for Research to Practice.

What industry is Research to Practice in?

Research to Practice's product category is Continuing Medical Education (Oncology). Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 611 and its SIC code is 8200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireResearch To Practice Unveils New Digital Platform for Oncology EducationResearch To Practice (RTP), part of The Lockwood Group, announced the launch of its fully redesigned digital platform for oncology education, offering over 300 hours of accredited content across 225+ activities featuring 260+ leading investigators and clinical experts. The platform provides a streamlined user experience with single sign-on, robust search functionality, and direct integration with CME/NCPD certification systems. This launch represents RTP's continued investment in accessible oncology education across digital, live, and on-demand channels.PR NewswireThe Lockwood Group Expands Capabilities by Welcoming Research To PracticeThe Lockwood Group announced the acquisition of Research To Practice (RTP), an oncology-focused medical education company specializing in accredited continuing education for healthcare professionals. The acquisition expands The Lockwood Group's capabilities in the oncology space, combining RTP's 40+ years of expertise in cancer clinician education with Lockwood's existing suite of medical communications, regulatory consulting, and market access services. The companies state the partnership will expand global reach and improve access to evidence-based education for oncology clinicians and patients worldwide.Pulse 2.0The Lockwood Group Acquires Research To Practice To Expand Global Oncology Education And Clinical InsightsThe Lockwood Group has acquired Research To Practice, a specialist oncology education provider founded over 40 years ago by Dr. Neil Love. The acquisition strengthens The Lockwood Group's global healthcare services platform, adding RTP's accredited continuing medical education programs spanning live symposia, webinars, podcasts, and multimedia events. The combined organization aims to expand its reach in delivering evidence-based oncology education to clinicians, researchers, and patients worldwide.Hartford Business JournalCT medical PR firm buys medical education companyThe Lockwood Group, a Stamford-based healthcare public relations firm, has acquired Research To Practice, a Miami-based medical education company specializing in oncology education for healthcare professionals. Research To Practice, founded four decades ago by medical oncologist Dr. Neil Love, creates content for live symposia, podcasts, webinars, and roundtables. Financial terms of the deal were not disclosed.ThelockwoodgrpThe Lockwood Group Expands Capabilities by Welcoming Research To PracticeThe Lockwood Group, a global healthcare services platform, has announced the acquisition of Research To Practice (RTP), a company specializing in accredited oncology-focused medical education for healthcare professionals. RTP, founded over four decades ago by medical oncologist Neil Love, MD, delivers continuing education through live symposia, podcasts, webinars, and other interactive formats. The acquisition is positioned as a strategic move to enhance The Lockwood Group's medical education offerings and expand its reach in the oncology space.PR NewswireOncology Leaders Champion Innovation and Collaboration To Advance Cancer CareFlorida Cancer Specialists & Research Institute is hosting its 2025 Clinical Summit this week in Fort Myers, Florida, a three-day event bringing together oncology physicians, clinical practice providers, and executive leaders to advance cancer patient care through learning and collaboration. The summit features sessions presented by Research to Practice on applying new cancer research data, along with keynote addresses from Liza Marshall and Dr. John Marshall on the patient and caregiver cancer experience, and a fireside chat with Olympian Chaunté Lowe. FCS operates nearly 100 locations across Florida with over 250 physicians and 280 nurse practitioners and physician assistants, serving patients with all forms of cancer and blood disorders.